Visual outcomes of pan-retinal photocoagulation in diabetic retinopathy at one-year follow-up and associated risk factors

Mohan, Rema; Sujatha, P.L.; Pradeepa, Rajendra

doi:10.4103/0301-4738.16171

Cited by 27 publications

(21 citation statements)

References 0 publications

Supporting

Mentioning

Contrasting

Unclassified

Order By: Relevance

“…This was comparable to study by Mohan Rema et al 5 who found the mean duration of diabetic to be 14 years.…”

Section: Paired T Testsupporting

confidence: 80%

See 1 more Smart Citation

Visual Outcome Following Panretinal Photocoagulation in Proliferative Diabetic Retinopathy

Sindhu¹,

Padmavathi²

2018

jebmh

View full text Add to dashboard Cite

BACKGROUNDDiabetes mellitus can be called as a noninfectious pandemic and the incidence of diabetic retinopathy is also uncontrollable. This vision-threatening complication can be treated by early diagnosis and effective treatment like panretinal photocoagulation.The aim of the study is to evaluate the effect of panretinal photocoagulation on visual acuity, colour vision, contrast sensitivity and severity of visual field changes.

show abstract

“…This was comparable to study by Mohan Rema et al 5 who found the mean duration of diabetic to be 14 years.…”

Section: Paired T Testsupporting

confidence: 80%

“…Mohan Rema 5 et al in their retrospective study showed that the mean age of the patients who underwent panretinal photocoagulation was 53 years.…”

Section: Paired T Testmentioning

confidence: 99%

Visual Outcome Following Panretinal Photocoagulation in Proliferative Diabetic Retinopathy

Sindhu¹,

Padmavathi²

2018

jebmh

View full text Add to dashboard Cite

show abstract

“…Visual acuity improved in 23% and was unchanged in 61%. Rema et al [24] studied the outcome of patients with type 2 diabetes and PDR after panretinal laser treatment. Seventy-three percent of patients with visual acuity of 6/9 or better maintained their vision.…”

Section: Panretinal Laser Treatment Of Diabetic Retinopathymentioning

confidence: 99%

Laser Treatment of Diabetic Retinopathy

Lang

2007

Developments in Ophthalmology

View full text Add to dashboard Cite

Laser treatment of diabetic retinopathy is still the gold standard of treatment for focal and diffuse diabetic macular edema and proliferative diabetic retinopathy. When properly treated, the 5-year risk of blindness is reduced by 90% in patients with proliferative diabetic retinopathy and the risk of visual loss from macular edema is reduced by 50%. However, only about 35-50% of patients with diabetes mellitus receive regular eye examinations, which are important for timely diagnosis and proper treatment. The necessary goals are better patient education to improve the control of diabetes and better screening programs to reduce the risk of blindness from diabetic retinopathy.

show abstract

“…A retrospective study conducted by Rema and colleagues 48 in 5000 T2DM patients who underwent a retinal examination between 1995 and 1999 at DMDSC reported that, of the 261 eyes of 160 patients who underwent panretinal photocoagulation, 73% of 191 eyes with good visual acuity (6/9) at baseline maintained the same vision at 1-year follow-up. Of the 53 eyes with visual acuity of 6/12-6/36 at baseline, 58.5% maintained same vision and 18.9% improved their vision at follow-up.…”

Section: Researchmentioning

confidence: 99%

“…Using the DEMR database of DMDSC, several retrospective, cross-sectional, and follow-up studies have been published. [39][40][41][42][43][44][45][46][47][48] Some of these are briefly reviewed here. Studies have been performed to determine the prevalence of, and risk factors for, diabetic retinopathy (DR), 40 proteinuria, 41 microalbuminuria, 42 and neuropathy.…”

Section: Researchmentioning

confidence: 99%

Use of a Large Diabetes Electronic Medical Record System in India: Clinical and Research Applications

Pradeepa

Anbalagan

Jebarani

et al. 2011

J Diabetes Sci Technol

Self Cite

View full text Add to dashboard Cite

Background: The diabetes electronic medical record (DEMR) has emerged as an effective information management tool with the potential to improve diabetes care and research. This study reports on the usefulness of the DEMR system at Dr. Mohan's Diabetes Specialities Centre (DMDSC), Chennai, India, for clinical and research purposes. Methods: The DEMR, set up in 1996 at DMDSC, connects data of nine centers/clinics in different geographical areas in Southern India. The present data analysis is based on a total of 226,228 patients registered in the DEMR system at DMDSC between the years 1991 and 2010. Results: The DEMR included data of 139,906 male and 86,322 female patients, of whom 92.6% had type 2 diabetes mellitus (T2DM), 1.4% had type 1 diabetes mellitus (T1DM), and the rest had other types. Patients with T2DM had higher prevalence rates of neuropathy (33.1% vs 13.0%, p < .001), microalbuminuria (25.5% vs 20.0%, p < .001), coronary artery disease (17.5% vs 9.2%, p < .001) and peripheral vascular disease (3.9% vs 2.8%, p = .017) compared with T1DM patients, while prevalence of diabetic retinopathy was similar (37.9% vs 35.7%, p = .06). Prevalence of microvascular and macrovascular complications of diabetes increased with increasing glycated hemoglobin levels ( p for trend < .001) and increasing diabetes duration ( p for trend < .001). Conclusions: The DEMR helps track diabetes care and is a valuable tool for research.

show abstract

Visual outcomes of pan-retinal photocoagulation in diabetic retinopathy at one-year follow-up and associated risk factors

Cited by 27 publications

References 0 publications

Visual Outcome Following Panretinal Photocoagulation in Proliferative Diabetic Retinopathy

Visual Outcome Following Panretinal Photocoagulation in Proliferative Diabetic Retinopathy

Laser Treatment of Diabetic Retinopathy

Use of a Large Diabetes Electronic Medical Record System in India: Clinical and Research Applications

Contact Info

Product

Resources

About